Accelero/epilepsie - Detection of nocturnal epileptic convulsions in pediatric patients based on accelometers.
From 01-09-2009 to 31-08-2013
Description
The aims of this project are (a) to validate and further refine the detection algorithm to reach a sensitivity of 90% and a false-positive rate of at most 3 per night in *20 paediatric patients* with convulsions (epileptic seizures with motor component such as: tonic manifestations, tonic-clonic manifestations, jerks or other seizures with motor components) (b) to develop a *wireless* prototype system for *real-time monitoring of nocturnal convulsions *at home and (c) to *investigate the therapeutic impact* of having available an “objective” measure of the number of nocturnal seizures over a longer period of time.Berten Ceulemans (spokesperson)
Team
- Berten Ceulemans, Coordinator (External)
- Sabine Van Huffel, Promoter
Financing
Funding: IWT - Agentschap voor Innovatie door Wetenschap en Technologie
Program/Grant Type: IWT TBM - VLAIO TBM Projects Applied Biomedical Research with a Primary Social finality
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.
